Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,075
Closed -$38.8K 661
2018
Q4
$38.8K Hold
1,075
0.01% 386
2018
Q3
$47.9K Sell
1,075
-58,059
-98% -$2.66M 0.01% 372
2018
Q2
$2.54M Buy
59,134
+6,047
+11% +$245K 0.42% 44
2018
Q1
$2.19M Buy
53,087
+34,090
+179% +$1.44M 0.44% 53
2017
Q4
$752K Buy
18,997
+16,508
+663% +$661K 0.13% 136
2017
Q3
$97.8K Buy
2,489
+2,454
+7,011% +$94K 0.02% 266
2017
Q2
$1.36K Sell
35
-1,018
-97% -$40.3K ﹤0.01% 462
2017
Q1
$48.2K Buy
+1,053
New +$48.7K 0.01% 268

Other funds holding AVT

Exane Derivatives's AVT Position: Q1 2019 in Review

Exane Derivatives sold out of Avnet (AVT) in Q1 2019, closing a stake of 1,075 shares — an estimated $38.8K sold.

Exane Derivatives first reported a position in AVT in Q1 2017 and held it in 8 quarters. The position peaked at $2.54M in Q2 2018. 329 funds tracked by Wall St. Rank hold AVT as of Q1 2019.

  • Exane Derivatives reported no remaining Avnet position as of Q1 2019 after selling out during the quarter.
  • Exane Derivatives sold 1,075 Avnet shares in Q1 2019, an estimated $38.8K.
  • Exane Derivatives first reported a position in Avnet in Q1 2017 and held it in 8 quarters.
  • Exane Derivatives's Avnet position peaked at $2.54M in Q2 2018.
  • 329 funds tracked by Wall St. Rank held Avnet as of Q1 2019.

Based on Exane Derivatives's 13F filing for Q1 2019, filed 24 Apr 2019.